Trulieve Cannabis Corp.
General ticker "TRLV" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.6B (TTM average)
Trulieve Cannabis Corp. follows the US Stock Market performance with the rate: 45.3%.
Estimated limits based on current volatility of 4.1%: low 10.85$, high 11.79$
Factors to consider:
- Current price 17.1% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.80$, 9.40$]
- 2026-12-31 to 2027-12-31 estimated range: [3.73$, 7.70$]
Short-term TRLV quotes
Long-term TRLV plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $1,181.18MM |
| Operating Expenses | $1,032.86MM |
| Operating Income | $148.32MM |
| Non-Operating Income | $-56.85MM |
| Interest Expense | $63.45MM |
| Income(Loss) | $91.47MM |
| Taxes | $208.11MM |
| Net Income(Loss)* | $-116.38MM |
| Stockholders Equity | $1,161.23MM |
| Inventory | $242.30MM |
| Assets | $2,696.10MM |
| Operating Cash Flow | $272.82MM |
| Capital expenditure | $60.51MM |
| Investing Cash Flow | $13.50MM |
| Financing Cash Flow | $-270.50MM |
| Earnings Per Share** | $-0.61 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.